Sanofi and Regeneron Pharmaceuticals announced Tuesday mid-stage data presented at the American Thoracic Society meeting and published in the NEJM showing that the experimental drug dupilumab cut the Full story
**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.